Next, Kaplan–Meier survival analysis was conducted and showed that higher expression of DCP1B was associated with favorable overall survival (OS) and disease-free survival (DFS) of NSCLC patients (Fig. 3E). This evidence concerns the gene DCP1B and non-small cell lung carcinoma.